Eggly Susan, Albrecht Terrance L, Harper Felicity W K, Foster Tanina, Franks Melissa M, Ruckdeschel John C
Program in Communication and Behavioral Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Patient Educ Couns. 2008 Jan;70(1):143-8. doi: 10.1016/j.pec.2007.09.019. Epub 2007 Nov 5.
To describe the frequency, context and type of oncologists' recommendations to patients that they participate in a clinical trial and to analyze the relationship between recommendations and patients' decisions to participate.
Data included 38 video recorded outpatient interactions during which 15 oncologists invited 38 patients to participate in clinical trials. We described the frequency, context, and type of oncologists' recommendations and analyzed the relationship between these factors and patient decisions to participate and socio-demographic characteristics.
Sixty-eight percent (n=26) of the 38 interactions included an explicit recommendation. Most recommendations were unprompted by patients and/or companions and were tailored to individual patients. A significant relationship was found between recommendations and patients' decisions to participate. Positive trends were found between receiving a recommendation and being female and having higher education.
Oncologists routinely make recommendations to patients during the presentation of clinical trials. These recommendations may influence patients' decisions and may occur more frequently with some demographic groups.
Oncologists should be aware of the potential influence of their recommendations when discussing clinical trials with patients.
描述肿瘤学家建议患者参与临床试验的频率、背景和类型,并分析这些建议与患者参与决定之间的关系。
数据包括38次门诊互动的视频记录,期间15名肿瘤学家邀请38名患者参与临床试验。我们描述了肿瘤学家建议的频率、背景和类型,并分析了这些因素与患者参与决定及社会人口统计学特征之间的关系。
38次互动中有68%(n = 26)包含明确的建议。大多数建议并非由患者和/或同伴提出,而是针对个体患者量身定制的。建议与患者的参与决定之间存在显著关系。在接受建议与女性及高学历之间发现了积极趋势。
肿瘤学家在介绍临床试验时经常向患者提出建议。这些建议可能会影响患者的决定,并且在某些人口群体中可能更频繁地出现。
肿瘤学家在与患者讨论临床试验时应意识到其建议的潜在影响。